Get startedLog in
    Picture of Dawnrays Pharmaceutical (Holdings) logo

    2348 — Dawnrays Pharmaceutical (Holdings) Cashflow Statement

    0.000.00%
    hk flag iconLast trade - 00:00
    HealthcareBalancedSmall CapSuper Stock
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for Dawnrays Pharmaceutical (Holdings), fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

    2020
    December 31st
    2021
    December 31st
    2022
    December 31st
    2023
    December 31st
    2024
    December 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:ARSARSARSARSARS
    Standards:
    HKAS
    HKAS
    HKAS
    HKAS
    HKAS
    Status:FinalFinalFinalFinalFinal
    Net Income/Starting Line331439438414637
    Depreciation
    Amortisation
    Non-Cash Items5.4-43.8-2.01-119-277
    Unusual Items
    Equity in Net Earnings/Losses
    Other Non-Cash Items
    Changes in Working Capital-93.4-59.9-68.5-40.3-246
    Change in Accounts Receivable
    Change in Inventories
    Change in Prepaid Expenses
    Change in Accounts Payable
    Change in Other Liabilities
    Other Operating Cash Flow
    Cash from Operating Activities303393434338220
    Capital Expenditures-162-313-204-200-126
    Purchase of Fixed Assets
    Other Investing Cash Flow Items18928.929.4-188331
    Sale of Business
    Sale of Fixed Assets
    Sale/Maturity of Investment
    Change in Net Investments
    Purchase of Investments
    Change in Net Intangibles
    Other Investing Cash Flow
    Cash from Investing Activities26.4-284-175-388205
    Financing Cash Flow Items117.530.5-0.529-3.16
    Other Financing Cash Flow
    Total Cash Dividends Paid
    Net Issuance / Retirement of Stock
    Net Issuance / Retirement of Debt
    Cash from Financing Activities-328-130-92.72.07-189
    Foreign Exchange Effects
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash-0.135-20.7174-44.9249